Hangzhou Highlightll News
We strive to discover breakthrough medicines which would have high impact on health care
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018- 205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
January 19,2023 From:
